Ultrasensitive prostate-specific antigen assays and their clinical application

Clinical Chemistry

Volumn 42, Issue 6 SUPPL., 1996, Pages 853-857

  Diamandis, Eleftherios P ^a,b   Yu, He ^a   Melegos, Dimitrios N ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD; CHEMISTRY; FEMALE; HUMAN; IMMUNOASSAY; MALE; NOTE; PROSTATE TUMOR; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

FEMALE; HUMANS; IMMUNOASSAY; MALE; MICROCHEMISTRY; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY;

EID: 0030162052     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.6.853     Document Type: Article

References (26)

1. Stamey TA. Lower limits of detection, biological detection limits, functional sensitivity, or residual cancer detection limit? Sensitivity reports on PSA assays mislead clinicians. Clin Chem 1996;42: 849-52.
2. Yu H, Diamandis EP. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin Chem 1993;39:2108-14.
3. Liedtke RJ, Kroon G, Batjer JD. Modified assay of prostate-specific antigen with a detection limit <0.01 μg/L. Clin Chem 1993;39: 2150-4.
4. Khosravi MJ, Papanastasiou-Diamandi A, Mistry J. An ultrasensitive immunoassay for prostate specific antigen based on conventional colorimetric detection. Clin Biochem 1995;28:407-14.
5. Vessella RL, Noteboom J, Lange PH. Evaluation of the Abbott IMx® automated immunoassay of prostate-specific antigen. Clin Chem 1992;38:2044-54.
6. Klee GG, Dodge LA, Zincke H, Oesterling JE. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay. J Urol 1994;151:94-8.
7. Stamey TA, Graves HCB, Wehner N, Ferrari M, Freiha FS. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol 1993;149:787-92.
8. Prestigiacomp AF, Stamey TA. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection or residual cancer after radical prostatectomy. J Urol 1994;152:1515-9.
9. Graves HCB, Wehner N, Stamey TA. Ultrasensitive radioimmunoassay of prostate-specific antigen. Clin Chem 1992;38:735-42.
10. Vessella RL. Trends in immunoassays of prostate-specific antigen: serum complexes and ultrasensitive [Editorial]. Clin Chem 1993;39:2035-9.
11. Vessella RL, Noteboom J, Lange PH, Rittenhouse H, Liu R, Kusnierz E. Ultrasensitive PSA immunoassays. How low do we need to go? J Urol 1993;149:484A.
12. Diamandis EP. Immunoassays with time-resolved fluorescence spectroscopy. Principles and applications. Clin Biochem 1988; 21:139-50.
13. Yu H, Diamandis EP, Prestigiacomo AF, Stamey TA. Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor doubling time after radical prostatectomy. Clin Chem 1995;41:430-4.
14. Yu H, Diamandis EP. Measurement of serum prostate specific antigen levels in females and in prostatectomized males with an ultrasensitive immunoassay technique. J Urol 1995;153: 1004-8.
15. Diamandis EP, Yu H. New biological functions of prostate specific antigen? J Clin Endocrinol Metab 1995;80:1515-7.
16. Yu H, Diamandis EP, Sutherland DJA. Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994;27:75-9.
17. Diamandis EP, Yu H, Sutherland DJA. Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994;32:301-10.
18. Monne M, Croce CM, Yu H, Diamandis EP. Molecular characterization of prostate specific antigen mRNA expressed in breast tumors. Cancer Res 1994;54:6344-7.
19. Yu H, Diamandis EP. Prostate-specific antigen in milk of lactating women. Clin Chem 1995;41:54-8.
20. Yu H, Diamandis EP, Monne M, Croce CM. Oral contraceptive-induced expression of prostate specific antigen in the female breast. J Biol Chem 1995;270:6615-8.
21. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, et al. Prostate specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 1995;55:2104-10.
22. Clements A, Mukhtar A. Glandular kallikreins and prostate specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 1994;78:1536-9.
23. Van Krieken JH. Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry. Am J Surg Pathol 1993;17:410-4.
24. Yu H, Diamandis EP. Prostate-specific antigen immunoreactivity in amniotic fluid: Clin Chem 1995;41:204-10.
25. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP. Ultrasensitive detection of prostate-specific antigen by a new time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem 1996;42:675-84.
26. Graves HCB. Prostate-specific antigen comes of age in diagnosis and management of prostate cancer [Editorial]. Clin Chem 1992; 38:1930-2.